Cargando…
Anti-inflammatory effects of PGE(2) in the lung: role of the EP(4) receptor subtype
BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airway. Current treatment options (long acting β-adrenoceptor agonists and glucocorticosteroids) are not optimal as they are only effective in certain patient groups and safety concerns exist...
Autores principales: | Birrell, Mark A, Maher, Sarah A, Dekkak, Bilel, Jones, Victoria, Wong, Sissie, Brook, Peter, Belvisi, Maria G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516010/ https://www.ncbi.nlm.nih.gov/pubmed/25939749 http://dx.doi.org/10.1136/thoraxjnl-2014-206592 |
Ejemplares similares
-
MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies
por: Wong, Sissie, et al.
Publicado: (2009) -
TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung
por: Eltom, Suffwan, et al.
Publicado: (2014) -
Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma
por: Baker, Katie, et al.
Publicado: (2016) -
Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016) -
Modelling the asthma phenotype: impact of cigarette smoke exposure
por: Belvisi, Maria G., et al.
Publicado: (2018)